b'
Delight over the funding of EpiPens.
\\nPharmac will fund the adrenaline auto-injectors for people who\'ve experienced anaphylaxis, or are at significant risk of doing so, from February next year.
\\nAround 12,000 people are expected to qualify in the first year.
\\nAllergy New Zealand Chief Executive Mark Dixon says it\'s the best news allergy sufferers have had in the more than 40 years the organisation\'s been representing them.
\\nHe says the affected patient group is going to be over the moon and he\'s so happy for them.
\\nLISTEN ABOVE
\\n\\xa0
See omnystudio.com/listener for privacy information.
'